Dodge & Cox’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.24B | Sell |
58,662,974
-9,854,995
| -14% | -$534M | 1.78% | 15 |
|
|
2025
Q4 | $3.36B | Sell |
68,517,969
-9,885,765
| -13% | -$461M | 1.81% | 15 |
|
|
2025
Q3 | $3.38B | Sell |
78,403,734
-354,135
| -0.4% | -$13.8M | 1.83% | 16 |
|
|
2025
Q2 | $3.02B | Buy |
78,757,869
+106,036
| +0.1% | +$4.05M | 1.7% | 19 |
|
|
2025
Q1 | $3.05B | Buy |
78,651,833
+10,210,921
| +15% | +$374M | 1.74% | 18 |
|
|
2024
Q4 | $2.31B | Buy |
68,440,912
+353,749
| +0.5% | +$12.7M | 1.35% | 26 |
|
|
2024
Q3 | $2.78B | Sell |
68,087,163
-249,975
| -0.4% | -$10.2M | 1.57% | 22 |
|
|
2024
Q2 | $2.63B | Sell |
68,337,138
-525,170
| -0.8% | -$22.1M | 1.58% | 22 |
|
|
2024
Q1 | $2.95B | Sell |
68,862,308
-164,485
| -0.2% | -$6.78M | 1.71% | 20 |
|
|
2023
Q4 | $2.56B | Sell |
69,026,793
-254,390
| -0.4% | -$9.13M | 1.62% | 21 |
|
|
2023
Q3 | $2.51B | Sell |
69,281,183
-330,085
| -0.5% | -$11.7M | 1.69% | 19 |
|
|
2023
Q2 | $2.48B | Sell |
69,611,268
-95,800
| -0.1% | -$3.44M | 1.66% | 21 |
|
|
2023
Q1 | $2.48B | Buy |
69,707,068
+4,774,116
| +7% | +$167M | 1.69% | 21 |
|
|
2022
Q4 | $2.28B | Buy |
64,932,952
+6,348,963
| +11% | +$211M | 1.56% | 21 |
|
|
2022
Q3 | $1.72B | Sell |
58,583,989
-810,189
| -1% | -$30.7M | 1.31% | 28 |
|
|
2022
Q2 | $3.23B | Sell |
59,394,178
-9,206,319
| -13% | -$508M | 2.24% | 13 |
|
|
2022
Q1 | $3.74B | Sell |
68,600,497
-2,215,058
| -3% | -$120M | 2.27% | 14 |
|
|
2021
Q4 | $3.9B | Buy |
70,815,555
+401,224
| +0.6% | +$20.9M | 2.42% | 11 |
|
|
2021
Q3 | $3.36B | Sell |
70,414,331
-153,020
| -0.2% | -$7.69M | 2.19% | 14 |
|
|
2021
Q2 | $3.51B | Buy |
70,567,351
+209,555
| +0.3% | +$10.1M | 2.3% | 14 |
|
|
2021
Q1 | $3.14B | Buy |
70,357,796
+20,009,190
| +40% | +$908M | 2.24% | 14 |
|
|
2020
Q4 | $2.32B | Buy |
50,348,606
+14,348,081
| +40% | +$659M | 1.83% | 21 |
|
|
2020
Q3 | $1.69B | Buy |
36,000,525
+2,782,329
| +8% | +$139M | 1.55% | 24 |
|
|
2020
Q2 | $1.69B | Sell |
33,218,196
-2,010,356
| -6% | -$103M | 1.56% | 23 |
|
|
2020
Q1 | $1.67B | Sell |
35,228,552
-1,882,023
| -5% | -$100M | 1.8% | 23 |
|
|
2019
Q4 | $2.18B | Sell |
37,110,575
-1,556,940
| -4% | -$86.6M | 1.67% | 26 |
|
|
2019
Q3 | $2.06B | Buy |
38,667,515
+81,101
| +0.2% | +$4.17M | 1.7% | 27 |
|
|
2019
Q2 | $1.93B | Buy |
38,586,414
+120,858
| +0.3% | +$6.06M | 1.56% | 29 |
|
|
2019
Q1 | $2.01B | Buy |
38,465,556
+76,366
| +0.2% | +$3.82M | 1.65% | 25 |
|
|
2018
Q4 | $1.83B | Sell |
38,389,190
-14,600
| -0% | -$719K | 1.68% | 25 |
|
|
2018
Q3 | $1.93B | Sell |
38,403,790
-122,880
| -0.3% | -$6.24M | 1.48% | 29 |
|
|
2018
Q2 | $1.94B | Sell |
38,526,670
-314,904
| -0.8% | -$15.9M | 1.55% | 25 |
|
|
2018
Q1 | $1.9B | Buy |
38,841,574
+3,574,940
| +10% | +$166M | 1.53% | 27 |
|
|
2017
Q4 | $1.56B | Buy |
35,266,634
+23,380,124
| +197% | +$1.08B | 1.21% | 33 |
|
|
2017
Q3 | $603M | Buy |
11,886,510
+11,862,760
| +49,948% | +$602M | 0.49% | 64 |
|
|
2017
Q2 | $1.28M | Sell |
23,750
-2,000
| -8% | -$107K | ﹤0.01% | 131 |
|
|
2017
Q1 | $1.36M | Sell |
25,750
-3,660
| -12% | -$186K | ﹤0.01% | 131 |
|
|
2016
Q4 | $1.42M | Sell |
29,410
-4,160
| -12% | -$205K | ﹤0.01% | 131 |
|
|
2016
Q3 | $1.81M | Sell |
33,570
-1,840
| -5% | -$101K | ﹤0.01% | 126 |
|
|
2016
Q2 | $1.92M | Sell |
35,410
-29,600
| -46% | -$1.56M | ﹤0.01% | 122 |
|
|
2016
Q1 | $3.29M | Sell |
65,010
-25,216
| -28% | -$1.26M | ﹤0.01% | 108 |
|
|
2015
Q4 | $4.55M | Sell |
90,226
-72,106
| -44% | -$3.68M | ﹤0.01% | 106 |
|
|
2015
Q3 | $7.8M | Sell |
162,332
-9,819,266
| -98% | -$511M | 0.01% | 92 |
|
|
2015
Q2 | $520M | Sell |
9,981,598
-8,767,643
| -47% | -$494M | 0.47% | 62 |
|
|
2015
Q1 | $1.08B | Sell |
18,749,241
-418,200
| -2% | -$24M | 1% | 39 |
|
|
2014
Q4 | $1.02B | Sell |
19,167,441
-11,703,888
| -38% | -$655M | 0.95% | 38 |
|
|
2014
Q3 | $1.77B | Sell |
30,871,329
-17,309,511
| -36% | -$1.06B | 1.7% | 22 |
|
|
2014
Q2 | $3.22B | Sell |
48,180,840
-128,400
| -0.3% | -$8.69M | 3.07% | 7 |
|
|
2014
Q1 | $3.23B | Sell |
48,309,240
-74,480
| -0.2% | -$5.04M | 3.3% | 7 |
|
|
2013
Q4 | $3.23B | Sell |
48,383,720
-648,760
| -1% | -$42.1M | 3.37% | 6 |
|
|
2013
Q3 | $3.07B | Sell |
49,032,480
-516,287
| -1% | -$33.2M | 3.49% | 5 |
|
|
2013
Q2 | $3.09B | Buy |
+49,548,767
| New | +$3.14B | 3.68% | 3 |
|
Other funds holding GSK
JEST